Evidence map›Paper›PMID 26986800›Full record

ArticleAIDS research and human retroviruses

Increases in NKG2C Expression on T Cells and Higher Levels of Circulating CD8

Vida L Hodara, Laura M Parodi, M Shannon Keckler, Luis D Giavedoni

Open access · greenAbstract read
In one paragraph

Article in AIDS research and human retroviruses. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. A role of CD20Frontiers in immunology · 2025
    Article
  2. The origin of human CD20Frontiers in immunology · 2024
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Vida L Hodara1 Department of Virology and Immunology, Texas Biomedical Research Institute , San Antonio, Texas.
Laura M Parodi1 Department of Virology and Immunology, Texas Biomedical Research Institute , San Antonio, Texas.
M Shannon Keckler3 Division of Healthcare Quality Promotion, Centers for Diseases Control and Prevention , Atlanta, Georgia .
Luis D Giavedoni1 Department of Virology and Immunology, Texas Biomedical Research Institute , San Antonio, Texas.
Texas Biomedical Research Institute · US

Funding

The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
NIH HHS P51 OD011133
6 · The paper itself

Abstract

Vaccines based on live attenuated viruses are highly effective immunogens in the simian immunodeficiency virus (SIV)/rhesus macaque animal model and offer the possibility of studying correlates of protection against infection with virulent virus. We utilized a tether system for studying, in naive macaques and animals vaccinated with a live-attenuated vaccine, the acute events after challenge with pathogenic SIV. This approach allowed for the frequent sampling of small blood volumes without sedation or restraining of the animals, thus reducing the confounding effect of sampling stress. Before challenge, vaccinated animals presented significantly higher levels of proliferating and activated B cells than naive macaques, which were manifested by high expression of CD8 on B cells. After SIV challenge, the only changes observed in protected vaccinated macaques were significant increases in expression of the NK marker NKG2C on CD4 and CD8 T cells. We also identified that infection of naive macaques with SIV resulted in a transient peak of expression of CD20 on CD8 T cells and a constant rise in the number of B cells expressing CD8. Finally, analysis of a larger cohort of vaccinated animals identified that, even when circulating levels of vaccine virus are below the limit of detection, live attenuated vaccines induce systemic increases of IP-10 and perforin. These studies indicate that components of both the innate and adaptive immune systems of animals inoculated with a live-attenuated SIV vaccine respond to and control infection with virulent virus. Persistence of the vaccine virus in tissues may explain the elevated cytokine and B-cell activation levels. In addition, our report underpins the utility of the tether system for the intensive study of acute immune responses to viral infections.

Indexed as

Gene ExpressionAnimalsB-LymphocytesCD4-Positive T-LymphocytesCD8 AntigensCD8-Positive T-LymphocytesMacaca mulattaNK Cell Lectin-Like Receptor Subfamily CSAIDS VaccinesSimian Acquired Immunodeficiency SyndromeVaccines, AttenuatedCD8 AntigensNK Cell Lectin-Like Receptor Subfamily CSAIDS VaccinesVaccines, AttenuatedacutechallengecytokinesimmunityinflammationlymphocytesmacaquesNKG2CrhesusSIVsterilizingvaccine

Identifiers

PMID26986800
PMCPMC5067875
OpenAlexW2299450392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.